Literature DB >> 9397991

Hepatic expression of c-Myb in chronic human liver disease.

T Kitada1, S Seki, K Nakatani, N Kawada, T Kuroki, T Monna.   

Abstract

C-Myb is a sequence-specific DNA binding protein that regulates the expression of genes involved in cell proliferation and differentiation. The present study was designed to elucidate the role of c-Myb in the pathogenesis of chronic liver disease by an immunohistochemical approach. In normal (control) livers, few or no hepatic cells were positive for c-Myb. In livers from patients with chronic viral hepatitis, positive staining for c-Myb was found not only in spindle-shaped mesenchymal cells in expanded portal areas, but also in perisinusoidal cells (PSCs) within liver lobules. In cirrhotic livers, a few PSCs within lobules were positive for c-Myb, while no staining was seen in fibrous septa. Immunoelectron microscopy revealed that c-Myb-positive PSCs displayed morphological features of hepatic stellate cells. Other sinusoidal lining cells including Kupffer cells and sinusoidal endothelial cells, as well as hepatocytes, were all negative for c-Myb. Dual c-Myb/alpha-smooth muscle actin (alphaSMA) staining revealed that more than 97% of c-Myb-positive cells were alphaSMA-positive. Moreover, dual c-Myb/proliferating cell nuclear antigen (PCNA) staining showed that approximately 70% of c-Myb-positive cells also expressed PCNA. The labeling index (LI) (number of c-Myb-positive cells/0.1 mm2) significantly correlated with serum transaminase concentrations and increased in parallel with the disease activity. However, the LI showed no correlation with the degree of fibrosis. These results suggest that c-Myb may be involved in stellate cell activation and proliferation in chronically diseased human livers, and that the level of c-Myb expression is associated with the activity of chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397991     DOI: 10.1053/jhep.1997.v26.pm0009397991

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Effects of c-myb antisense RNA on TGF-beta1 and beta1-I collagen expression in cultured hepatic stellate cells.

Authors:  Hui-Hui Ma; Ji-Lu Yao; Gang Li; Chun-Lan Yao; Xue-Juan Chen; Shao-Ji Yang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

2.  Oxidative Stress and Hepatic Stellate Cells: A PARADOXICAL RELATIONSHIP.

Authors:  Chandrashekhar R Gandhi
Journal:  Trends Cell Mol Biol       Date:  2012

3.  Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.

Authors:  Senthil K Venugopal; Joy Jiang; Tae-Hun Kim; Yong Li; Si-Si Wang; Natalie J Torok; Jian Wu; Mark A Zern
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

4.  Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing.

Authors:  Femke Heindryckx; François Binet; Markella Ponticos; Krista Rombouts; Joey Lau; Johan Kreuger; Pär Gerwins
Journal:  EMBO Mol Med       Date:  2016-07-01       Impact factor: 12.137

5.  A novel antifibrotic strategy utilizing conditioned media obtained from miR-150-transfected adipose-derived stem cells: validation of an animal model of liver fibrosis.

Authors:  Kwang Yeol Paik; Kee-Hwan Kim; Jung Hyun Park; Jae Im Lee; Ok-Hee Kim; Ha-Eun Hong; Haeyeon Seo; Ho Joong Choi; Joseph Ahn; Tae Yun Lee; Say-June Kim
Journal:  Exp Mol Med       Date:  2020-03-09       Impact factor: 8.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.